Cipher Pharmaceuticals (CPHRF) Short Interest Ratio & Short Volume → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free CPHRF Stock Alerts $6.23 -0.27 (-4.15%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Cipher Pharmaceuticals Short Interest DataCurrent Short Volume13,100 sharesPrevious Short Volume15,700 sharesChange Vs. Previous Month-16.56%Dollar Volume Sold Short$88,949.00Short Interest Ratio / Days to Cover0.4Last Record DateApril 15, 2024Today's Trading Volume4,600 sharesAverage Trading Volume19,055 sharesToday's Volume Vs. Average24% Short Selling Cipher Pharmaceuticals ? Sign up to receive the latest short interest report for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCPHRF Short Interest Over TimeCPHRF Days to Cover Over TimeCPHRF Percentage of Float Shorted Over Time Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Cipher Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202413,100 shares $88,949.00 -16.6%N/A0.4 $6.79 3/31/202415,700 shares $103,472.42 +34.2%N/A0.2 $6.59 3/15/202411,700 shares $61,659.00 +265.6%N/A0.2 $5.27 2/29/20243,200 shares $16,672.32 +6.7%N/A0.1 $5.21 2/15/20243,000 shares $16,140.00 -45.5%N/A0.1 $5.38 1/15/20245,400 shares $23,652.00 +217.7%N/A0.6 $4.38 Get the Latest News and Ratings for CPHRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,700 shares $7,123.00 -66.7%N/A0.1 $4.19 12/15/20235,100 shares $23,970.00 +218.8%N/A0.3 $4.70 11/30/20231,600 shares $7,072.00 No ChangeN/A0.1 $4.42 11/15/20231,600 shares $6,352.00 -70.9%N/A0 $3.97 10/31/20235,500 shares $17,277.15 +223.5%N/A0.8 $3.14 10/15/20231,700 shares $5,253.00 +1,600.0%N/A0.2 $3.09 9/30/2023100 shares $318.47 -90.9%N/A0 $3.18 9/15/20231,100 shares $3,630.11 -15.4%N/A0.1 $3.30 8/31/20231,300 shares $3,783.00 +44.4%N/A0.2 $2.91 8/15/2023900 shares $2,412.00 No ChangeN/A0.1 $2.68 6/15/2023900 shares $2,512.62 No ChangeN/A0.6 $2.79 5/15/20231,000 shares $2,590.00 No ChangeN/A0.1 $2.59 4/15/2023900 shares $2,277.00 -76.3%N/A0.1 $2.53 3/31/20233,800 shares $9,386.00 No ChangeN/A0.2 $2.47 2/15/20231,000 shares $2,760.00 +11.1%N/A0.1 $2.76 1/31/2023900 shares $2,286.00 No ChangeN/A0.1 $2.54 1/15/2023900 shares $2,480.22 -43.8%N/A0.1 $2.76 12/30/20221,600 shares $4,471.84 -33.3%N/A0.4 $2.79 12/15/20222,400 shares $6,707.04 +9.1%N/A0.4 $2.79 11/30/20222,200 shares $5,610.00 -4.4%N/A0.2 $2.55 11/15/20222,300 shares $5,839.93 -28.1%N/A0.3 $2.54 10/31/20223,200 shares $7,588.48 +60.0%N/A0.5 $2.37 10/15/20222,000 shares $4,381.60 +33.3%N/A0.3 $2.19 9/30/20221,500 shares $3,450.00 -46.4%N/A0.1 $2.30 9/15/20222,800 shares $6,524.00 +1,300.0%N/A0.3 $2.33 8/31/2022200 shares $380.00 -33.3%N/A0.1 $1.90 8/15/2022300 shares $550.89 -40.0%N/A0 $1.84 7/31/2022500 shares $855.00 No ChangeN/A0.1 $1.71 7/15/2022500 shares $850.00 -16.7%N/A0.2 $1.70 6/30/2022600 shares $1,019.34 No ChangeN/A0.2 $1.70 6/15/2022600 shares $1,122.00 -50.0%N/A0.1 $1.87 5/31/20221,200 shares $2,211.47 +50.0%N/A1.2 $1.84 5/15/2022800 shares $1,504.00 No ChangeN/A0.1 $1.88 4/30/2022800 shares $1,472.00 -38.5%N/A0.1 $1.84This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry CPHRF Short Interest - Frequently Asked Questions What is Cipher Pharmaceuticals' current short interest? Short interest is the volume of Cipher Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 13,100 shares of CPHRF short. Learn More on Cipher Pharmaceuticals' current short interest. Is Cipher Pharmaceuticals' short interest increasing or decreasing? Cipher Pharmaceuticals saw a drop in short interest in April. As of April 15th, there was short interest totaling 13,100 shares, a drop of 16.6% from the previous total of 15,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Cipher Pharmaceuticals stock? Short selling CPHRF is an investing strategy that aims to generate trading profit from Cipher Pharmaceuticals as its price is falling. CPHRF shares are trading down $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cipher Pharmaceuticals? A short squeeze for Cipher Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CPHRF, which in turn drives the price of the stock up even further. How often is Cipher Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CPHRF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 1933 Industries Short Interest 4Cable TV International Short Interest 4Front Ventures Short Interest AB Science Short Interest Acreage Short Interest Acreage Short Interest Aleafia Health Short Interest Almirall Short Interest Alvotech Short Interest American Green Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CPHRF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative